Physicians who accept money from any company promoting a medical intervention should not be involved in influencing public policy.  

Pharmaceutical companies well understand the benefits of lobbying and promotion and pay so well for it that it far outstrips the amount of money spend developing their products.

Monies so spent are toxic to the system and should be prevented.